IMMUNOPHAGE
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Dec 2022)
What this means for you
This application is over — abandoned 19 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88896315
- Mark type
- Stylized text
- Filed
- 30 Apr 2020
- Published for opposition
- 23 Mar 2021
- Abandoned
- 19 Dec 2022
- Attorney of record
- Christine M Baker
Goods and services
- Class 005 — Pharmaceuticals: Vaccines for treating cancer and infectious diseases; Pharmaceuticals for treating cancer and infectious diseases; immuno-oncology pharmaceuticals and therapeutics; pharmaceuticals and therapeutics that teach the immune system to recognize cancer and infectious diseases
Owner
- PPI Holdings, Inc, Rockville, MD, US
- PPI Holdings, Inc, Gaithersburg, MD, US
Prosecution history
- 19 Dec 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Dec 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 19 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2022 — SOU EXTENSION 2 GRANTED
- 17 May 2022 — SOU EXTENSION 2 FILED
- 17 May 2022 — SOU TEAS EXTENSION RECEIVED
- 29 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 May 2021 — SOU EXTENSION 1 GRANTED
- 27 May 2021 — SOU EXTENSION 1 FILED
- 27 May 2021 — SOU TEAS EXTENSION RECEIVED
- 18 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION
- 03 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER